KLK3 and metastatic prostate carcinoma: This model could predict OS from five pretreatment factors, namely patient age at initial treatment, pretreatment serum PSA level, clinical T stage, EOD, and biopsy Gleason sum, in patients with bone-metastatic prostate cancer.